Further investigation of the molecular mechanisms that regulate Axin protein levels via tankyrases and deregulation in disease conditions is likely to provide additional avenues for treating Wnt-dependent cancers and other Wnt-related diseases. This evidence concerns the gene AXIN1 and cancer.